The Leukemia & Lymphoma Society Honors FDA Associate Director, Greg Reaman, M.D., with the Return of Child Award For Immediate Release Contact: Andrea…
News Release
With studies showing between 30-60% of blood cancer patients at risk of death if infected with the COVID-19 virus compared to patients who are cancer-…
GAITHERSBURG, MD - October 27, 2020 - NexImmune, a clinical-stage biotechnology company developing unique non-genetically-engineered T cell immunother…
Rye Brook, NY – October 6, 2022 – In the wake of the destruction caused by Hurricane Fiona and Hurricane Ian, The Leukemia & Lymphoma Society (LLS) an…
News Release
About 1:4 blood cancer patients fail to produce detectable antibodies after COVID-19 vaccination with results varying substantially by type of blood c…
Matthew Matasar is a hematology and oncology specialist at Memorial Sloan-Kettering Cancer Center in New York City. He has a Translational Research Pr…
The Leukemia & Lymphoma Society (LLS) has heard great concerns from patients, caregivers, volunteers, healthcare professionals, researchers, community…
News Release
Blood is life.And during National Native American Heritage Month, it has special meaning.Teenager Rachel S’s story is all about her “blood:” Her proud…
For many, summer is a time to get out of the house. Vacations, backyard cookouts, going for walks in the park—there's no better time of year for havin…
no-float 100 AUGUST 7, 2023 - The Follicular Lymphoma Foundation (…
Research: Grants
Analysis of the LLS model supports the potential that it can be replicated to increase patient access to clinical trials across all cancer types
FOR IMMEDIATE RELEASEContact: Tina [email protected](202) 835-3581
Hope. When times are tough, it’s often hope people look for. We want things to work out, to see reasons to keep going. You hear “hope” a lot in conjun…
Blog
Royalty Pharma plc (Nasdaq: RPRX) today announced a charitable commitment totaling $7.5 million to The Leukemia & Lymphoma Society (LLS), a global lea…
We’ve come a long way and we continue to make substantial progress. The outlook for blood cancer patients is better than ever, but it’s still nowhere …
The Leukemia & Lymphoma Society (LLS) and Walgreens are in your corner. Since 2019, Walgreens has helped to raise more than $30 million for LLS and S…
By definition, love can be either a noun or a verb. For many people, it represents everything we aspire to—falling in love, loving, feeling loved. It …
no-float 100 Rye Brook, NY, March 12, 2024 – The Leukemia & Lympho…
100 Rye Brook, N.Y. – June 1, 2023 – Subaru of America, Inc. today announced that it will rene…
Latest Campaign Reinforces IHOP's 26-Year Commitment to Raising Funds for LLS’s Mission …
Collaboration Efforts Designed to Advance Health Education and Address Racial Disparities in Blood Cancers Affecting Black Communities
News Release
The organization will enable blood cancer patients to gain one million years of life by 2040
News Release
Funds will provide lifesaving treatments and support The LLS Children’s Initiative research pillar dedicated to pediatric cancer care innovation
The U.S. Food and Drug Administration (FDA) today approved the CAR T-cell treatment axicabtagene ciloleucel (Yescarta®) for patients with follicular l…
The Leukemia & Lymphoma Society (LLS) is now Blood Cancer United. Learn more.